4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-036711
Co-Chief Executive Officer acquired 180,118 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klee Justin B. Co-Chief Executive Officer | 2025-03-06 | Grant or award | +180,118 | 3,376,766 | D | ||
| Derivatives | |||||||
| Klee Justin B. Co-Chief Executive Officer | 2025-03-06 | Grant or award · Stock Option (right to buy) | +270,177 | 270,177 | D | ||
Loading xslF345X05/ownership.xml…